Advertisement

Biotherapy

, Volume 7, Issue 2, pp 115–123 | Cite as

Enhancement of interferon-β production with sphingomyelin from fermented milk

  • Kazuhiro Osada
  • Kazuhiko Nagira
  • Kiichiro Teruya
  • Hirofumi Tachibana
  • Sanetaka Shirahata
  • Hiroki Murakami
Article

Abstract

A fermented milk, Kefir, contains an active substance which enhances IFN-β secretion of a human osteosarcoma line MG-63 treated with a chemical inducer, poly I: poly C. The active substance in the fermented milk was identified to be sphingomyelin (SpM) by a combined use of a fast atom bombardment mass spectrometry (FAB-MS) and a fast atom bombardment tandem mass spectrometry (FAB-MS/MS). SpM from fermented milk (F-SpM) was a mixture of four molecular species of SpMs having C21-, C22-, C23- and C24-fatty acids. F-SpM enhanced the IFN secretion 14 times, SpMs from other sources also enhanced moderately (2–3 times). Sphingosine and lysosphingomyelin also enhanced the activity but ceramide and cerebroside did not.

Key words

Interferon-β Sphingomyelin Sphingosine Fermented milk 

Abbreviations

IFN-β

interferon-β

SpM

sphingomyelin

Lyso-SpM

lysosphingomyelin

SpS

sphingosine

FAB-MS

fast atom bombardment mass spectrometry

FAB-MS/MS

fast atom bombardment tandem mass spectrometry

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stewart II WE. Interferon nomenclature. Nature (London) 1980; 286: 110.Google Scholar
  2. 2.
    Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Annu Rev Biochem 1987; 56; 727–77.PubMedGoogle Scholar
  3. 3.
    Galanos DS, Kapoulas VM. Isolation of polar lipids from triglyceride mixtures. J Lipid Research 1962; 3: 134–6.Google Scholar
  4. 4.
    Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911–17.PubMedGoogle Scholar
  5. 5.
    Tan YH, Armstrong JA, Ke YH, Ho M. Regulation of cellular interferon production: enhancement by antimetabolites. Proc Natl Acad Sci, USA 1970; 64: 464–71.Google Scholar
  6. 6.
    Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 1971; 8: 871–4.PubMedGoogle Scholar
  7. 7.
    Yamada K, Matsumura K, Suzaki M, Shirahata S, Murakami H. Stimulation and inhibition of interferon-β production of human diploid fibroblasts by foodstuffs. Agric Biol Chem 1991; 55: 829–32.PubMedGoogle Scholar
  8. 8.
    White DA. Phospholipid composition of mammalian tissues. In: Ausell GB, et al, eds. Form and function of phospholipids. Amsterdam: Elsevier, 1973: 441–82.Google Scholar
  9. 9.
    Tahara T, Shirahata S, Osada K, Tachibana H, Shinohara K, Murakami H. Stimulation of interferon-β production of cultured cells by phospholipids in foodstuffs. Biosci Biotech Biochem 1992; 56: 1465–6.Google Scholar
  10. 10.
    Memll Jr AH, Victoria LS. Modulation of protein kinase C and diverse cell functions by SpS-a pharmacologically interesting compound linking sphingolipids and signal transduction. Biochimica Biophys Acta 1989; 1010: 131–9.Google Scholar
  11. 11.
    Hannun YA, Bell RH. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 1989; 243: 500–7.PubMedGoogle Scholar
  12. 12.
    Hannun YA, Loomis CR, Merrill A, Bell RM. Sphingosine inhibition of protein kinase C activity and of phorbol dibutylate bindingin vitro and in human platelets. J Biol Chem 1986; 261: 12604–9.PubMedGoogle Scholar
  13. 13.
    Hannun YA, Greenberg CS, Bell RMS. Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways. J Biol Chem 1987; 262: 13620–6.PubMedGoogle Scholar
  14. 14.
    Chow SC, Ng J, Nordestedt C, Fredholm BB, Jondal M. Phosphoinositide breakdown and evidence for protein kinase C involvement during human NK killing. Cell Immunol 1988; 114: 96–103.PubMedGoogle Scholar
  15. 15.
    Weikel CS, Murphy CF, Orozco E, Ravdin JI. Phorbol esters specifically enhance the cytolytic activity ofEntamoeba histolytica. Infect Immun 1988; 56: 1485–91.PubMedGoogle Scholar
  16. 16.
    Nutter LM, Grill SP, Li JS, Tan RS, Cheng YC. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells. Cancer Res 1987; 47: 4407–12.PubMedGoogle Scholar
  17. 17.
    Ballou LR, Barker SC, Postlethwaite AE, Kang AH. SpS potentiates IL-1-mediated prostaglandin E2 production in human fibroblasts. J Immunol 1990;145: 4245–51.PubMedGoogle Scholar
  18. 18.
    Candela M, Barker SC, Ballou LR. SpS synergistically stimulates tumor necrosis factorα-induced prostaglandin E2 production in human fibroblasts. J Exp Med 1991; 174: 1363–9.PubMedGoogle Scholar
  19. 19.
    Ballou LR. Sphingolipids and cell function. Immunology Today 1992; 13: 339–41.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1994

Authors and Affiliations

  • Kazuhiro Osada
    • 1
  • Kazuhiko Nagira
    • 2
  • Kiichiro Teruya
    • 1
  • Hirofumi Tachibana
    • 1
  • Sanetaka Shirahata
    • 1
  • Hiroki Murakami
    • 1
  1. 1.Graduate School of Genetic Resources TechnologyKyushu UniversityFukuokaJapan
  2. 2.Dojindo LaboratoriesKumamotoJapan

Personalised recommendations